48,059,533 Align Technology, Inc. $ALGN Shares Purchased by State Street Corp

State Street Corp raised its stake in shares of Align Technology, Inc. (NASDAQ:ALGN – Free Report) by 939.2% during the 3rd quarter, HoldingsChannel.com reports. The firm owned 53,176,557 shares of the medical equipment provider’s stock after acquiring an additional 48,059,533 shares during the quarter. State Street Corp owned 0.75% of Align Technology worth $7,069,459,000 as of its most recent filing with the SEC.

A number of other large investors have also made changes to their positions in the stock. Whittier Trust Co. grew its position in Align Technology by 46.6% during the third quarter. Whittier Trust Co. now owns 409 shares of the medical equipment provider’s stock worth $58,000 after buying an additional 130 shares in the last quarter. Private Wealth Asset Management LLC grew its holdings in shares of Align Technology by 1,636.7% during the 3rd quarter. Private Wealth Asset Management LLC now owns 1,563 shares of the medical equipment provider’s stock worth $227,000 after purchasing an additional 1,473 shares in the last quarter. Private Advisor Group LLC grew its holdings in shares of Align Technology by 9,220.4% during the 3rd quarter. Private Advisor Group LLC now owns 131,325 shares of the medical equipment provider’s stock worth $17,402,000 after purchasing an additional 129,916 shares in the last quarter. Ieq Capital LLC increased its position in shares of Align Technology by 280.1% during the third quarter. Ieq Capital LLC now owns 198,176 shares of the medical equipment provider’s stock valued at $26,443,000 after purchasing an additional 146,042 shares during the period. Finally, Colonial Trust Co SC increased its position in shares of Align Technology by 254,205.6% during the third quarter. Colonial Trust Co SC now owns 45,775 shares of the medical equipment provider’s stock valued at $6,057,000 after purchasing an additional 45,757 shares during the period. Institutional investors and hedge funds own 88.43% of the company’s stock.

Wall Street Analyst Weigh In

Several equities research analysts have issued reports on ALGN shares. Morgan Stanley lowered their price target on shares of Align Technology from $188.00 to $175.00 and set an “equal weight” rating on the stock in a report on Thursday, October 29th. Wall Street Zen downgraded shares of Align Technology from a “buy” rating to a “hold” rating in a report on Saturday, October 24th. Piper Sandler decreased their target price on shares of Align Technology from $235.00 to $205.00 and set an “overweight” rating on the stock in a research report on Wednesday, October 21st. Stifel Nicolaus decreased their target price on shares of Align Technology from $210.00 to $175.00 and set a “buy” rating on the stock in a research report on Friday, October 9th. Finally, Robert W. Baird cut shares of Align Technology from an “outperform” rating to a “neutral” rating and lowered their target price for the company from $218.00 to $162.00 in a research note on Thursday, October 15th. One equities research analyst has rated the stock with a Strong Buy rating, eight have given a Buy rating and eight have issued a Hold rating to the stock. Based on data from MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and a consensus target price of $193.08.

Check Out Our Latest Research Report on ALGN

Align Technology Price Performance

Align Technology stock opened at $155.13 on Friday. The company has a market capitalization of $10.94 billion, a PE ratio of 22.58, a price-to-earnings-growth ratio of 2.15 and a beta of 1.74. Align Technology, Inc. has a one year low of $132.63 and a one year high of $200.43. The business has a 50 day simple moving average of $152.50 and a 200 day simple moving average of $168.54.

Align Technology (NASDAQ:ALGN – Get Free Report) last announced its quarterly earnings results on Wednesday, October 28th. The medical equipment provider reported $2.80 earnings per share for the quarter, beating analysts’ consensus estimates of $2.77 by $0.03. Align Technology had a return on equity of 15.96% and a net margin of 11.83%. The firm had revenue of $1.01 billion for the quarter, compared to analysts’ expectations of $1 billion. During the same period in the prior year, the business posted $2.61 earnings per share. The business’s revenue was up 1.9% compared to the same quarter last year. Equities analysts anticipate that Align Technology, Inc. will post 9.21 earnings per share for the current fiscal year.

About Align Technology

(Free Report)

Align Technology, Inc. develops, manufactures and markets digital orthodontic and restorative dentistry products. Its best-known offering is the Invisalign system, which uses a series of custom-made clear aligners to straighten teeth. The company also sells Vivera retainers and iTero intraoral scanners, which support digital dental imaging and treatment planning. Founded in 1997, Align helped popularize clear-aligner orthodontic treatment as an alternative to traditional braces. Its digital dentistry portfolio also includes exocad software, used by dental professionals and laboratories to design dental restorations.

Featured Stories

Want to see what other hedge funds are holding ALGN? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Align Technology, Inc. (NASDAQ:ALGN – Free Report).

Institutional Ownership by Quarter for Align Technology (NASDAQ:ALGN)

Receive News & Ratings for Align Technology Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Align Technology and related companies with MarketBeat.com's FREE daily email newsletter.